Safety and Effectiveness of Volumetric Computed Tomography of the Heart in Combination with a PharmacologicaTest with Adenosine Triphosphate in the Diagnosis of Coronary Heart Disease

Aim      To evaluate safety and efficacy of sodium adenosine triphosphate (ATP) as a vasodilator in assessment of left ventricular (LV) myocardial perfusion and in verification of ischemia by cardiac volumetric computed tomography (CT).

Material and methods  The study included 58 patients with suspected ischemic heart disease (IHD). For all included patients, cardiac volumetric CT with a pharmacological ATP test was performed. The rate of adverse effects was analyzed during the ATP infusion. Results of the study were compared with data from using other noninvasive methods for IHD diagnosis by calculating Cohen’s kappa, the measure of agreement between two variables.

Results The test performed during CT showed good tolerability of the ATP infusion, a low rate of moderate adverse reactions (8.6 %), and the absence of severe side effects. Results of diagnosing IHD with cardiac volumetric CT with the ATP pharmacological test were comparable with data from using other methods for noninvasive verification of LV myocardial ischemia (bicycle ergometry, treadmill test, stress echocardiography) in combination with coronarography or CT coronarography.

Conclusion      ATP appears a safe pharmacological agent for diagnosing transient LV myocardial ischemia. ATP can be recommended as a vasodilator for evaluation of perfusion using cardiac volumetric CT.

1. Boytsov S.A., Samorodskaya I.V., Nikulina N.N., Yakushin S.S., Andreev E.M., Zairatyants O.V. et al. Comparative analysis of mortality from acute forms of ischemic heart disease during a 15-year period in the Russian Federation and the United States and the factors influencing its formation. Therapeutic Archive. 2017;89(9):53–9. DOI: 10.17116/terarkh201789953-59

2. Karpov Yu.A., Kukharchuk V.V., Lyakishev A.A., Lupanov V.P., Panchenko E.P., Komarov A.L. et al. Diagnosis and treatment of chronic ischemic heart disease. Kardiologicheskij Vestnik. 2015;10(3):3–33.

3. Taylor A, Yang E. Comparing American and European Guidelines for the Initial Diagnosis of Stable Ischaemic Heart Disease. European Heart Journal. 2020;41(7):811–5. DOI: 10.1093/eurheartj/ehaa057

4. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV et al. Low Diagnostic Yield of Elective Coronary Angiography. New England Journal of Medicine. 2010;362(10):886–95. DOI: 10.1056/NEJMoa0907272

5. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, FunckBrentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407–77. DOI: 10.1093/eurheartj/ehz425

6. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2012;60(24):e44–164. DOI: 10.1016/j.jacc.2012.07.013

7. Yamada H, Azuma A, Hirasaki S, Kobara M, Akagi A, Shima T et al. Intracoronary adenosine 5′-triphosphate as an alternative to papaverine for measuring coronary how reserve. The American Journal of Cardiology. 1994;74(9):940–1. DOI: 10.1016/0002- 9149(94)90591-6

8. Miyagawa M, Kumano S, Sekiya M, Watanabe K, Akutzu H, Imachi T et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. Journal of the American College of Cardiology. 1995;26(5):1196–201. DOI: 10.1016/0735-1097(95)00304-5

9. Karpova I.E., Samoĭlenko L.E., Soboleva G.N., Sergienko V.B., Karpov Yu.A., Chernisheva I.E. et al. Adenosine Triphosphate Stress 99mTC-MIBI Single-Photon Emission Computed Tomography in the Diagnosis Miocardial Iscemia in Patients With Microvascular Angina. Kardiologiia. 2014;54(7):4–8.

10. Shiode N, Kato M, Nakayama K, Shinohara K, Kurokawa J, Yamagata T et al. Effect of Adenosine Triphosphate on Human Coronary Circulation. Internal Medicine. 1998;37(10):818–25. DOI: 10.2169/internalmedicine.37.818

11. Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. Journal of the American College of Cardiology. 1996;27(2):304–10. DOI: 10.1016/0735-1097(95)00465-3

12. Headrick JP, Peart JN, Reichelt ME, Haseler LJ. Adenosine and its receptors in the heart: Regulation, retaliation and adaptation. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2011;1808(5):1413–28. DOI: 10.1016/j.bbamem.2010.11.016

13. Jacobson KA, Gao Z-G. Adenosine receptors as therapeutic targets. Nature Reviews Drug Discovery. 2006;5(3):247–64. DOI: 10.1038/nrd1983

14. Kozlovski V.I., Zinchuk V.V., Stankevich P.B., Khlopitski S. The role of adenosine in the regulation of the functions of the cardiovascular system. Journal of the Grodno State Medical University. 2007;1(17):49–53.

15. Skrabanja ATP, Bouman EAC, Dagnelie PC. Potential value of adenosine 5′-triphosphate (ATP) and adenosine in anaesthesia and intensive care medicine. British Journal of Anaesthesia. 2005;94(5):556–62. DOI: 10.1093/bja/aei093

16. Boeynaems J-M, Wilkin F, Marteau F, Duhant X, Savi P, Suarez Gonzalez N et al. P2Y receptors: New subtypes, new functions. Drug Development Research. 2003;59(1):30–5. DOI: 10.1002/ddr.10199

17. Belhassen B, Pelleo A. Adenosine triphosphate and adenosine: Perspectives in the acute management of paroxysmal supraventricular tachycardia. Clinical Cardiology. 1985;8(9):460–4. DOI: 10.1002/clc.4960080903

18. Alberti C, Monopoli A, Casati C, Forlani A, Sala C, Nador B et al. Mechanism and Pressor Relevance of the Short-Term Cardiovascular and Renin Excitatory Actions of the Selective A2A-Adenosine Receptor Agonists. Journal of Cardiovascular Pharmacology. 1997;30(3):320–4. DOI: 10.1097/00005344-199709000-00008

19. Dhalla AK, Wong M-Y, Wang W-Q, Biaggioni I, Belardinelli L. Tachycardia Caused by A2A Adenosine Receptor Agonists Is Mediated by Direct Sympathoexcitation in Awake Rats. Journal of Pharmacology and Experimental Therapeutics. 2006;316(2):695–702. DOI: 10.1124/jpet.105.095323

20. Proctor Hj, Thiet M, Palladino Gw. ATP-MgCl2 treatment prior to hypoxic-hypotension. Circulatory shock. 1983;11(1):65–71. PMID: 6640855

21. Shapiro Mj, Jellinek M, Pyrros D, Sundine M, Baue Ae. Clearance and maintenance of blood nucleotide levels with adenosine triphosphatemagnesium chloride injection. Circulatory shock. 1992;36(1):62–7. PMID: 1551186

22. Nguyen K-L, Bandettini WP, Shanbhag S, Leung SW, Wilson JR, Arai AE. Safety and tolerability of regadenoson CMR. European Heart Journal - Cardiovascular Imaging. 2014;15(7):753–60. DOI: 10.1093/ehjci/jet278

23. Kido T, Watanabe K, Saeki H, Shigemi S, Matsuda T, Yamamoto M et al. Adenosine triphosphate stress dual-source computed tomography to identify myocardial ischemia: comparison with invasive coronary angiography. SpringerPlus. 2014;3(1):75. DOI: 10.1186/2193-1801-3-75

24. Kurata A, Mochizuki T, Koyama Y, Haraikawa T, Suzuki J, Shigematsu Y et al. Myocardial Perfusion Imaging Using Adenosine Triphosphate Stress Multi-Slice Spiral Computed Tomography. Circulation Journal. 2005;69(5):550–7. DOI: 10.1253/circj.69.550

25. Soboleva G.N., Gaman S.A., Ternovoy S.K., Karpov Yu.A., Minasyan A.A., Shariya M.A. et al. The study of myocardial perfusion by cardiac volumetric computed tomography, combined with adenosine triphosphate test, in a patient with painless myocardial ischemia and atherosclerosis of the coronary arteries. Therapeutic Archive. 2020;92(4):76–9. DOI: 10.26442/00403660.2020.04.000201

26. Soboleva G.N., Gaman S.A., Ternovoy S.K., Shariya M.A., Karpova I.E., Karpov Yu.A. Disturbance of myocardial perfusion in non-obstructive coronary arteries by volume computed tomography combined with adenosine triphosphate pharmacological test. Russian Electronic Journal of Radiology. 2018;8(3):273–8. DOI: 10.21569/2222-7415-2018-8-3-273-278

27. Magalhães TA, Kishi S, George RT, Arbab-Zadeh A, Vavere AL, Cox C et al. Combined coronary angiography and myocardial perfusion by computed tomography in the identification of flow-limiting stenosis – The CORE320 study: An integrated analysis of CT coronary angiography and myocardial perfusion. Journal of Cardiovascular Computed Tomography. 2015;9(5):438–45. DOI: 10.1016/j.jcct.2015.03.004